Overview

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if mitoxantrone is more effective with or without docetaxel. PURPOSE: Randomized phase III trial to compare the effectiveness of mitoxantrone with or without docetaxel in treating women who have metastatic breast cancer with a poor prognosis.
Phase:
Phase 3
Details
Lead Sponsor:
Arbeitsgemeinschaft fur Internistische Onkologie
Treatments:
Docetaxel
Mitoxantrone